|
Tom DiLenge became BIO's Vice President & General Counsel in May 2006. Previously, Tom served as Acting General Counsel, from February 2006, and as Deputy General Counsel, from November 2005.
Prior to joining BIO, Tom served as the Chief Counsel and Policy Director for the House Homeland Security Committee and previously served as a senior counsel for the House Energy and Commerce Committee. On the Hill, he was a leading expert in the area of public health emergency preparedness.
Prior to working on Capitol Hill, Tom worked at the Washington, D.C. office of the international law firm Mayer, Brown, Rowe and Maw, where he participated in a sophisticated general and appellate commercial litigation practice. In this capacity, he represented a host of publicly traded and privately held corporations, including those in the agricultural, healthcare, and accounting industries. He worked closely with in-house corporate counsel on compliance, investigative, and litigation matters, with a particular focus on antitrust issues and investigations.
Tom graduated summa cum laude from Fordham University in 1988 and graduated with honors from the University of Virginia School of Law in 1993.
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.
|
Printer Friendly